Rhythm Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
CEODavid P. Meeker
CEODavid P. Meeker
Employees283
Employees283
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2008
Founded2008
Employees283
Employees283
RYTM Key Statistics
Market cap4.05B
Market cap4.05B
Price-Earnings ratio-14.44
Price-Earnings ratio-14.44
Dividend yield—
Dividend yield—
Average volume765.00K
Average volume765.00K
High today$63.98
High today$63.98
Low today$61.39
Low today$61.39
Open price$62.11
Open price$62.11
Volume356.78K
Volume356.78K
52 Week high$68.58
52 Week high$68.58
52 Week low$35.17
52 Week low$35.17
RYTM News
TipRanks 4d
Promising Outlook for Rhythm Pharmaceuticals: Buy Rating Backed by Positive Phase 3 Results and Market Expansion PlansRhythm Pharmaceuticals (RYTM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tazeen Ahmad from Bank...
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%